| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
4,717,666 |
$665,191 |
$0.1410 |
13 Aug 2021 |
By Jonathan Couchman |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
2,043,024 |
$288,066 |
$0.1410 |
13 Aug 2021 |
By Xstelos Corp. |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
633,264 |
$89,290 |
$0.1410 |
13 Aug 2021 |
By Myrexis, Inc. |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
350,000 |
$49,350 |
$0.1410 |
13 Aug 2021 |
By Couchman Family Fund |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$0 |
$0.6800 |
20 Aug 2025 |
By Couchman Family Fund |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$0 |
$0.6800 |
20 Aug 2025 |
By Myrexis, Inc. |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$0 |
$0.6800 |
20 Aug 2025 |
By Xstelos Holdings, Inc. |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$0 |
$0.6800 |
20 Aug 2025 |
Direct |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$0 |
$0.6800 |
20 Aug 2025 |
In retirement accounts |